Sign up for the lawsuit with the nation’s top lawyers here: https://theclassactionnews.com/oxbryta-retainer-agreement/
Pfizer, the manufacturer of Oxbryta decided in September 2024 to RECALL its sickle cell prescription medication Oxbryta, also called voxelotor, from the market due to safety concerns. The Oxbryta lawsuit is your option if you took Oxbryta and had a hospitalization, please contact our experienced lawyers for a consultation. It appears that the drug allegedly caused more harm than benefits to patients. Although patients took it for sickle cell treatment, it allegedly caused bad side effects like Vaso-Occlusive Crises (VOCs), organ failure and stroke in many patients. If you took the prescription Oxbryta from 2019 – 2024 and had a bad side effect, please fill out this form and contact our experienced attorneys.
We are partnered with the nation’s highly experienced attorneys who handle Oxbryta lawsuits for injured patients. Be cautious about signing an agreement with a law firm that is not experienced in handling mass tort claims. This case will be handled in a centralized national court with ALL OXBRYTA patient claims with significant side effects being heard in one place. You need an experienced attorney who does this type of case. Talk with us and ask any questions by calling 213-212-2202 or filling out the form.
The sickle cell community of advocates and doctors is shocked by this revelation by Pfizer, the manufacturer of Oxbryta. They should soon be notifying their patients about the recall and the plan for care, if they have not already. Fill out the form on this page to contact an attorney confidentially.
There was a study that Pfizer concluded they would pull the Oxbryta drug. Pfizer stated, “Pfizer’s decision is based on the totality of clinical data that now indicates the overall benefit of OXBRYTA no longer outweighs the risk in the approved sickle cell patient population. The data suggest an imbalance in vaso-occlusive crises and fatal events which require further assessment.” https://www.pfizer.com/news/press-release/press-release-detail/pfizer-voluntarily-withdraws-all-lots-sickle-cell-disease
Researchers reported in the study that there have been deaths among patients who were receiving it. European regulators also reported that patients in the study’s trials had higher rates of the pain crises (VOCs) that are hallmarks of sickle cell disease once they started on Oxbryta, also called voxelotor, than they did before taking the drug.
The FDA also issued a notice of recall of Oxbryta on September 26, 2024. https://www.fda.gov/drugs/drug-safety-and-availability/fda-alerting-patients-and-health-care-professionals-about-voluntary-withdrawal-oxbryta-market-due
Who are the lawyers who are representing clients who sign up with this lawsuit through our website? The nation’s top lawyers are known and have a reputation of legal leaders. Those lawyers are with the Aylstock Witkin Kreis & Overholtzlaw firm.
